These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

620 related items for PubMed ID: 31412809

  • 21. Secular trends in gram-negative resistance among urinary tract infection hospitalizations in the United States, 2000-2009.
    Zilberberg MD, Shorr AF.
    Infect Control Hosp Epidemiol; 2013 Sep; 34(9):940-6. PubMed ID: 23917908
    [Abstract] [Full Text] [Related]

  • 22. Empiric antibiotics pending bronchoalveolar lavage data in patients without pneumonia significantly alters the flora, but not the resistance profile, if a subsequent pneumonia develops.
    Thakkar RK, Monaghan SF, Adams CA, Stephen A, Connolly MD, Gregg S, Cioffi WG, Heffernan DS.
    J Surg Res; 2013 May; 181(2):323-8. PubMed ID: 22906560
    [Abstract] [Full Text] [Related]

  • 23. An International Prospective Cohort Study To Validate 2 Prediction Rules for Infections Caused by Third-generation Cephalosporin-resistant Enterobacterales.
    Deelen JWT, Rottier WC, Giron Ortega JA, Rodriguez-Baño J, Harbarth S, Tacconelli E, Jacobsson G, Zahar JR, van Werkhoven CH, Bonten MJM, ESBL-PREDICT Study Team.
    Clin Infect Dis; 2021 Dec 06; 73(11):e4475-e4483. PubMed ID: 32640024
    [Abstract] [Full Text] [Related]

  • 24. Cefiderocol: A new Antimicrobial for Complicated Urinary Tract Infection (CUTI) Caused by Carbapenem-resistant Enterobacteriaceae (CRE).
    Chatterjee S, Chakraborty DS, Choudhury S, Lahiry S.
    Curr Drug Res Rev; 2022 Dec 06; 14(1):20-23. PubMed ID: 34872487
    [Abstract] [Full Text] [Related]

  • 25. Changes in the incidence and antimicrobial susceptibility of healthcare-associated infections in a New York hospital system, 2006-2012.
    Cohen B, Liu J, Larson E.
    J Prev Med Hyg; 2017 Dec 06; 58(4):E294-E301. PubMed ID: 29707660
    [Abstract] [Full Text] [Related]

  • 26. Prevalence of multidrug-resistant Pseudomonas aeruginosa and carbapenem-resistant Enterobacteriaceae among specimens from hospitalized patients with pneumonia and bloodstream infections in the United States from 2000 to 2009.
    Zilberberg MD, Shorr AF.
    J Hosp Med; 2013 Oct 06; 8(10):559-63. PubMed ID: 24022878
    [Abstract] [Full Text] [Related]

  • 27. The impact of an antibiotic cycling program on empirical therapy for gram-negative infections.
    Merz LR, Warren DK, Kollef MH, Fridkin SK, Fraser VJ.
    Chest; 2006 Dec 06; 130(6):1672-8. PubMed ID: 17166981
    [Abstract] [Full Text] [Related]

  • 28. Perspectives on the use of ceftolozane/tazobactam: a review of clinical trial data and real-world evidence.
    Martin-Loeches I, Bruno CJ, DeRyke CA.
    Future Microbiol; 2024 Dec 06; 19(6):465-480. PubMed ID: 38252038
    [Abstract] [Full Text] [Related]

  • 29. Clinical experience of cefiderocol.
    Fariñas MC.
    Rev Esp Quimioter; 2022 Sep 06; 35 Suppl 2(Suppl 2):35-38. PubMed ID: 36193983
    [Abstract] [Full Text] [Related]

  • 30. Carbapenem-resistant Gram-negative pathogens in a German university medical center: Prevalence, clinical implications and the role of novel β-lactam/β-lactamase inhibitor combinations.
    Katchanov J, Asar L, Klupp EM, Both A, Rothe C, König C, Rohde H, Kluge S, Maurer FP.
    PLoS One; 2018 Sep 06; 13(4):e0195757. PubMed ID: 29649276
    [Abstract] [Full Text] [Related]

  • 31. A Novel Algorithm to Analyze Epidemiology and Outcomes of Carbapenem Resistance Among Patients With Hospital-Acquired and Ventilator-Associated Pneumonia: A Retrospective Cohort Study.
    Zilberberg MD, Nathanson BH, Sulham K, Fan W, Shorr AF.
    Chest; 2019 Jun 06; 155(6):1119-1130. PubMed ID: 30685333
    [Abstract] [Full Text] [Related]

  • 32. Prediction of Fluoroquinolone Resistance in Gram-Negative Bacteria Causing Bloodstream Infections.
    Dan S, Shah A, Justo JA, Bookstaver PB, Kohn J, Albrecht H, Al-Hasan MN.
    Antimicrob Agents Chemother; 2016 Apr 06; 60(4):2265-72. PubMed ID: 26833166
    [Abstract] [Full Text] [Related]

  • 33. Cefiderocol: A Siderophore Cephalosporin with Activity Against Carbapenem-Resistant and Multidrug-Resistant Gram-Negative Bacilli.
    Zhanel GG, Golden AR, Zelenitsky S, Wiebe K, Lawrence CK, Adam HJ, Idowu T, Domalaon R, Schweizer F, Zhanel MA, Lagacé-Wiens PRS, Walkty AJ, Noreddin A, Lynch Iii JP, Karlowsky JA.
    Drugs; 2019 Feb 06; 79(3):271-289. PubMed ID: 30712199
    [Abstract] [Full Text] [Related]

  • 34. Epidemiology of Ventilator-Associated Pneumonia, microbiological diagnostics and the length of antimicrobial treatment in the Polish Intensive Care Units in the years 2013-2015.
    Wałaszek M, Różańska A, Wałaszek MZ, Wójkowska-Mach J, Polish Society of Hospital Infections Team.
    BMC Infect Dis; 2018 Jul 06; 18(1):308. PubMed ID: 29976151
    [Abstract] [Full Text] [Related]

  • 35. High Prevalence of Antimicrobial-resistant Gram-negative Colonization in Hospitalized Cambodian Infants.
    Turner P, Pol S, Soeng S, Sar P, Neou L, Chea P, Day NP, Cooper BS, Turner C.
    Pediatr Infect Dis J; 2016 Aug 06; 35(8):856-61. PubMed ID: 27124686
    [Abstract] [Full Text] [Related]

  • 36. Antibiotic treatment of infections caused by carbapenem-resistant Gram-negative bacilli: an international ESCMID cross-sectional survey among infectious diseases specialists practicing in large hospitals.
    Papst L, Beović B, Pulcini C, Durante-Mangoni E, Rodríguez-Baño J, Kaye KS, Daikos GL, Raka L, Paul M, ESGAP, ESGBIS, ESGIE and the CRGNB treatment survey study group.
    Clin Microbiol Infect; 2018 Oct 06; 24(10):1070-1076. PubMed ID: 29410094
    [Abstract] [Full Text] [Related]

  • 37. Carbapenem-resistant Enterobacteriaceae bloodstream infections: A case-control study from a pediatric referral hospital in Argentina.
    Ruvinsky S, Voto C, Roel M, Deschutter V, Ferraro D, Aquino N, Reijtman V, Galvan ME, Motto E, García M, Sarkis C, Bologna R.
    Front Public Health; 2022 Oct 06; 10():983174. PubMed ID: 36091556
    [Abstract] [Full Text] [Related]

  • 38. The role of gram-negative bacteria in healthcare-associated pneumonia.
    Restrepo MI, Anzueto A.
    Semin Respir Crit Care Med; 2009 Feb 06; 30(1):61-6. PubMed ID: 19199188
    [Abstract] [Full Text] [Related]

  • 39. Effects of various antimicrobial stewardship programs on antimicrobial usage and resistance among common gram-negative bacilli causing health care-associated infections: A multicenter comparison.
    Lai CC, Shi ZY, Chen YH, Wang FD.
    J Microbiol Immunol Infect; 2016 Feb 06; 49(1):74-82. PubMed ID: 26586483
    [Abstract] [Full Text] [Related]

  • 40. Bloodstream infections in children caused by carbapenem-resistant versus carbapenem-susceptible gram-negative microorganisms: Risk factors and outcome.
    Ozsurekci Y, Aykac K, Cengiz AB, Basaranoglu ST, Sancak B, Karahan S, Kara A, Ceyhan M.
    Diagn Microbiol Infect Dis; 2017 Apr 06; 87(4):359-364. PubMed ID: 28089138
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 31.